Amanda Nelson is a Rheumatology/Immunology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3300 Thurston Bldg Cb # 7280
Chapel Hill, NC 275997280
Telephone
919-966-4191Registry record last updated 13 Aug 2008.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20242 payments
- Novo Nordisk IncProgram year20211 payment
- Myovant Sciences Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
45.4%Folate Analog Metabolic Inhibitor21.6%Methotrexate100%Part D<11 patientsAntirheumatic Agent12.4%Leflunomide100%Part D<11 patients+ 1 more class in this area
Antiparasitic
39.2%Antimalarial39.2%Hydroxychloroquine Sulfate100%Part D≥18 patientsMetabolism & gastrointestinal
15.5%Corticosteroid15.5%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Is the gut important in multiple joint osteoarthritis? A multimodal investigation in humans and pet dogs
Univ of North Carolina Chapel Hill
FY2026$626,073R01AR080733 - The Rheumatic and Musculoskeletal Disease Epidemiology and Outcomes Training Program at the University of North Carolina
Univ of North Carolina Chapel Hill
FY2026$210,873T32AR082310 - Mentoring in Patient Oriented Research in Osteoarthritis
Univ of North Carolina Chapel Hill
FY2026$197,119K24AR081368
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”